Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2015.519 | A review on Serotypes and In-vitro Antibiotic Susceptibilities of Streptococcus pneumoniae from Hospitalized Adult Patients in a Hong Kong Hospital, 2012 - 2014. |
Prof. IP Margaret 葉碧瑤 |
| 2022.473 | Enhanced surveillance of sepsis through application of rapid diagnostics and molecular typing tools |
Prof. IP Margaret 葉碧瑤 |
| 2021.041 | Burden of streptococcal infection and colonization in Hong Kong |
Prof. IP Margaret 葉碧瑤 |
| 2023.072 | Sealing the gaps: Lactobacillus spp. mediated mitigation of insulin resistance-induced intestinal epithelium dysfunction and modulation of carbapenem resistant Klebsiella pneumoniae infection in an in vivo model | Prof. IP Margaret |
| 2023.122 | A Belt and Road platform to track and tackle MRSA disease and carriage, elucidating their antimicrobial and biocide resistance, genetic diversity and transmission dynamics between humans, animals and the environment | Prof. IP Margaret |
| 2022.058 | Decolonization of carbapenemase-producing Enterobacteriaceae through modulation of the gut microbiota and its resistome |
Prof. IP Margaret 葉碧瑤 |
| 2023.071 | Epidemiology of Klebsiella pneumoniae by whole-genome sequencing | Prof. IP Margaret |
| 2020.561 | A retrospective review of pneumococcal disease and other respiratory infection in Hong Kong hospitals |
Prof. IP Margaret 葉碧瑤 |
| 2018.509 | A review on infections and colonization of Streptococcus agalactiae in Hong Kong, 2007-2021 | Prof. IP Margaret |
| 2018.628 | Resistome of gut microbiota and modulation in healthy Hong Kong population |
Prof. IP Margaret 葉碧瑤 |
| 2019.545 | Study for Monitoring Antimicrobial Resistance Trends (SMART) | Prof. IP Margaret |
| 2019.657 | Burden of Streptococcus agalactiae (GBS) disease in Hong Kong |
Prof. IP Margaret 葉碧瑤 |
| 2018.116 | Modulation of gut microbiota with probiotics: a pilot study |
Prof. IP Margaret 葉碧瑤 |
| 2019.013 | Surveillance of bacterial pathogens by whole-genome sequencing |
Prof. IP Margaret 葉碧瑤 |
| 2020.007 | One Health approach to Track and Target Antimicrobial Resistance (TnT-AMR) |
Prof. IP Margaret 葉碧瑤 |
| 2018.261 | Isolation of CD34 stem cells from cord blood |
Prof. IP Margaret 叶碧瑶 |
| 2020.608 | Surveillance of Streptococcus pneumoniae and respiratory viruses in children hospitalised for acute respiratory illnesses in Hong Kong (2017-2019) to assess the ongoing impact of pneumococcal conjugate vaccines | Prof. IP Margaret |
| 2008.030 | Factors Affecting Clinical Outcomes of Vancomyic Therapy for Methicillin-Resistant Staphylococcus Aureus Bactgeraemia | Dr Ip Margaret |
| 2010.305 | Evaluation of a nurse-led Comprehensive Child Development Service Program for high risk pregnant women in Hong Kong | Ms Ip Lai Sheung |
| 2008.494 | Compare the Clinical Outcomes of Non-operative Versus Operative Treatment in Mason Type II Radial Head Fracture, Restrospective Study | DR IP Kai Yuen |
| 2014.625 | The prevalence and risk factors associated with the use of Potentially Inappropriate Medication in Old Age Homes and Prince of Wales Hospital - a retrospective cohort study | Student Ip Kai Cheung |
| 2024.209 | Molecular Characterization of CDKL5 Deficiency Disorders (CDD) with Human Brain Samples | Prof. IP Jacque Pak Kan |
| 2022.290 | A Fifteen-year Retrospective Review on Livedoid Vasculopathy in a Tertiary Centre | Dr. IP Edric Chi Ching |
| 2021.028 | A pilot randomized controlled trial of integrative Motivational Interviewing and Contingency Management program (MICM) for dual-diagnosed patients to enhance psychiatric medication adherence |
Mr. IP Chi Kin 葉志堅 |
| 2017.381 | The feasibility study over the outcomes of substance abusers in residential detox centers when compared with video medical consultation verus face-to-face consultation |
Mr. IP Chi Kin 葉志堅 |
| 2020.383 | Effect of Acceptance and Commitment Therapy-based lifestyle counselling programme for people with early psychosis on physical activity: a pilot randomized controlled trial |
Mr. IP Chi Kin 葉志堅 |
| 2021.627 | Comparative efficacy and safety of treatments in Intracerebral Bleeding during Direct Oral Anticoagulant Usage – a population-based study |
Dr. IP Bonaventure Yiu Ming 葉耀明 |
| 2021.386 | Impact of COVID-19 Vaccines on Cerebrovascular Health – a community-based study | Dr. IP Bonaventure Yiu Ming |
| 2023.340 | Prognostication of Intracerebral hemorrhage – a population-based study | Dr. IP Bonaventure Yiu Ming |
| 2023.295 | A Real-life study of Anti-CGRP medication in Asian Patients with migraine (REAP) | Dr. IP Bonaventure Yiu Ming |
| 2021.349 | The Effect of Medication Prescription on First-ever Ischemic strokes - a territory-wide observational study |
Dr IP Bonaventure Yiu Ming 葉耀明 |
| 2022.414 | Effective Translation of Endovascular Thrombectomy Trials into Real-world Practice in the Asia-Pacific: a multicenter, prospective registry (ENDURE-APAC) |
Dr. IP Bonaventure Yiu Ming 葉耀明 |
| 2024.136 | Brain Health in Atrial Fibrillation – a prospective study | Dr. IP Bonaventure Yiu Ming |
| 2022.639 | Epidemiological Update on Migraine in Hong Kong |
Dr. IP Bonaventure Yiu Ming 葉耀明 |
| 2022.352 | Prevalence and Etiologies of Intracranial Stenosis in Patients with Antiphospholipid Syndrome: a cross sectional study |
Dr. IP Bonaventure Yiu Ming 葉耀明 |
| 2023.367 | A Phase 3, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Demonstrate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, for Stroke Prevention after an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack | Dr. IP Bonaventure Yiu Ming |
| 2022.008 | Colchicine Use in Intracranial Atherosclerotic Disease – a pilot open-labelled randomized trial |
Dr. IP Bonaventure Yiu Ming 葉耀明 |
| 2023.026 | Glucagon-like Peptide 1 Receptor Agonist in Acute Large Vessel Occlusion Stroke Treated by Reperfusion Therapies – a pilot study |
Dr. IP Bonaventure Yiu Ming 葉耀明 |
| 2022.241 | Brain Health in Oral Anticoagulant Recipients | Dr. IP Bonaventure Yiu Ming |
| 2022.333 | Direct Oral Anticoagulant Levels in Chinese Patients with Atrial Fibrillation – A Real- World Pharmacokinetic Study (DOAC-REAL) |
Dr. IP Bonaventure Yiu Ming 葉耀明 |
| 2023.524 | Intravenous Thrombolytic Therapy in Acute Ischemic Stroke Patients on Direct Oral Anticoagulants – A Prospective Multicenter Study | Dr. IP Bonaventure Yiu Ming |
| 2022.194 | Clinical outcome of Territory-wide Prehospital Stroke Notification in Hong Kong |
Dr. IP Bonaventure Yiu Ming 葉曜明 |
| 2023.602 | Precision Research Integrating Multiomics, Gut Microbiome and Advanced Imaging Assessment for Stroke, Neuroinflammatory and Neurodegenerative Diseases – PRIMMA Consortium | Dr. IP Bonaventure Yiu Ming |
| 2024.388 | Prevalence of Small Vessel Disease in Patients with Cardiovascular Risk Factors - A hospital-based study | Dr. IP Bonaventure Yiu Ming |
| 2024.304 | Evaluation of serum glial fibrillatory acidic protein and serum neurofilament light chain as biomarkers for patients with multiple sclerosis in Hong Kong | Dr. IP Bonaventure Yiu Ming |
| 2024.430 | Cardio- and Cerebrovascular Disease Biobank for Research | Dr. IP Bonaventure Yiu Ming |
| 2018.645 | Evolution of ischaemic stroke subtype in Hong Kong | Dr. IP Bonaventure Yiu Ming |
| 2020.427 | Ischemic Strokes while on NOAC – how compliance matters |
Dr. IP Bonaventure Yiu Ming 葉耀明 |
| 2020.376 | Monitoring of NOAC therapy: standardizing reference intervals |
Dr. IP Bonaventure Yiu Ming 葉耀明 |
| 2020.386 | Evaluation of Small Vessel Disease by 3D-rotational Angiography |
Dr. IP Bonaventure Yiu Ming 葉耀明 |
Page 149 of 254.